Table 1 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms gan James R. Larkin (14936324)

Awduron Eraill:

Figure 5 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms gan James R. Larkin (14936324)

Awduron Eraill:

Figure 3 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms gan James R. Larkin (14936324)

Awduron Eraill:

Figure 1 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms gan James R. Larkin (14936324)

Awduron Eraill:

Figure 4 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms gan James R. Larkin (14936324)

Awduron Eraill:

Figure 2 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms gan James R. Larkin (14936324)

Awduron Eraill:

Figure 4 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface gan Vinton W.T. Cheng (15020397)

Awduron Eraill:

Figure 2 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface gan Vinton W.T. Cheng (15020397)

Awduron Eraill:

Figure 6 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface gan Vinton W.T. Cheng (15020397)

Awduron Eraill:

Figure 1 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface gan Vinton W.T. Cheng (15020397)

Awduron Eraill:

Figure 5 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface gan Vinton W.T. Cheng (15020397)

Awduron Eraill:

Figure 3 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface gan Vinton W.T. Cheng (15020397)

Awduron Eraill: